Mapping Telemedicine in German Private Practice Urological Care: Implications for Transitioning beyond the COVID-19 Pandemic.


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
2021
Historique:
received: 15 01 2021
accepted: 22 02 2021
pubmed: 6 5 2021
medline: 10 7 2021
entrez: 5 5 2021
Statut: ppublish

Résumé

There are limited data on the use and concern of telemedicine among German urologists, and thus, there are no established guidelines for telemedical diagnosis, treatment, and prevention of urological indications. An anonymized survey was conducted among German private practice urologists during the 2019 coronavirus disease (COVID-19) pandemic. The χ2 test, Mann-Whitney U-test, and Kruskal-Wallis test were used for statistical analysis. 257 urologists were included in the final analysis. Thirty-five (14.0%) of urologists had used telemedicine as part of their consultation, and 221 (86.0%) had not used telemedicine. There was no difference between telemedicine adoption rates between rural and urban settings. Telemedicine users were significantly more satisfied with the information they had received regarding telemedicine issues. Users saw the greatest barrier to telemedicine that patients do not take up the offer of telemedicine. Nonusers were most concerned with unclear indications for telemedicine followed by lesser reimbursements during telemedicine than in-person visitations. Users were significantly more likely to use telemedicine beyond the COVID-19 pandemic. Urologists, who wanted to use the service in the future, wanted an active support by the German society of urology and guidelines for telemedicine. Last, users and nonusers preferred telemedicine for non-acute chronic diseases and follow-up visitations. Despite the COVID-19 pandemic, telemedicine remains a rarely used service among German private practice urologists. Ultimately, to overcome the current challenges, urologists require an active support for the service through the German Society of Urology and telemedical guidelines.

Sections du résumé

BACKGROUND BACKGROUND
There are limited data on the use and concern of telemedicine among German urologists, and thus, there are no established guidelines for telemedical diagnosis, treatment, and prevention of urological indications.
METHODS METHODS
An anonymized survey was conducted among German private practice urologists during the 2019 coronavirus disease (COVID-19) pandemic. The χ2 test, Mann-Whitney U-test, and Kruskal-Wallis test were used for statistical analysis.
RESULTS RESULTS
257 urologists were included in the final analysis. Thirty-five (14.0%) of urologists had used telemedicine as part of their consultation, and 221 (86.0%) had not used telemedicine. There was no difference between telemedicine adoption rates between rural and urban settings. Telemedicine users were significantly more satisfied with the information they had received regarding telemedicine issues. Users saw the greatest barrier to telemedicine that patients do not take up the offer of telemedicine. Nonusers were most concerned with unclear indications for telemedicine followed by lesser reimbursements during telemedicine than in-person visitations. Users were significantly more likely to use telemedicine beyond the COVID-19 pandemic. Urologists, who wanted to use the service in the future, wanted an active support by the German society of urology and guidelines for telemedicine. Last, users and nonusers preferred telemedicine for non-acute chronic diseases and follow-up visitations.
CONCLUSION CONCLUSIONS
Despite the COVID-19 pandemic, telemedicine remains a rarely used service among German private practice urologists. Ultimately, to overcome the current challenges, urologists require an active support for the service through the German Society of Urology and telemedical guidelines.

Identifiants

pubmed: 33951666
pii: 000515982
doi: 10.1159/000515982
pmc: PMC8247820
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

650-656

Informations de copyright

© 2021 S. Karger AG, Basel.

Références

Clin Genitourin Cancer. 2021 Feb;19(1):76-82.e6
pubmed: 32527682
Urology. 2016 Aug;94:10-6
pubmed: 27109596
J Med Syst. 1995 Feb;19(1):59-67
pubmed: 7790808
N Engl J Med. 2017 Oct 19;377(16):1585-1592
pubmed: 29045204
Eur Urol Focus. 2020 Sep 15;6(5):1111-1119
pubmed: 32576530
Nat Rev Urol. 2020 Jul;17(7):363-364
pubmed: 32405032
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Oct;58(10):1068-73
pubmed: 26324096
Telemed J E Health. 2004;10 Suppl 2:S-95-109
pubmed: 23570220
Pediatr Surg Int. 2021 Mar;37(3):389-395
pubmed: 33388961
Eur Urol Focus. 2020 Sep 15;6(5):1097-1103
pubmed: 32534969
Eur Urol. 2020 Dec;78(6):812-819
pubmed: 32654801
Telemed J E Health. 2015 Mar;21(3):233-41
pubmed: 25658882
Healthcare (Basel). 2014 Feb 12;2(1):74-93
pubmed: 27429261
Eur Urol. 2020 Dec;78(6):786-811
pubmed: 32616405
N Engl J Med. 2020 Aug 27;383(9):883-884
pubmed: 32846070
Eur Urol. 2020 Jul;78(1):21-28
pubmed: 32376137

Auteurs

Severin Rodler (S)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.
Arbeitsgruppe für Anwendung von künstlicher Intelligenz und digitalen Gesundheits-anwendungen in der Urologie, Klinikum der Universität München, Munich, Germany.

Julius M Schütz (JM)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Amelie Styn (A)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Philipp Weinhold (P)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Jozefina Casucelli (J)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Lennert Eismann (L)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Ricarda M Bauer (RM)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Michael Staehler (M)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Christian Stief (C)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.

Alexander Buchner (A)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.
Arbeitsgruppe für Anwendung von künstlicher Intelligenz und digitalen Gesundheits-anwendungen in der Urologie, Klinikum der Universität München, Munich, Germany.

Jan-Niclas Mumm (JN)

Klinik und Poliklinik für Urologie, Klinikum der Universität München, Munich, Germany.
Arbeitsgruppe für Anwendung von künstlicher Intelligenz und digitalen Gesundheits-anwendungen in der Urologie, Klinikum der Universität München, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH